Ziyad Al-Aly
GuatemalaepidemiologistMale8.0Global Dominance: 0.00%Ziyad Al-Aly is a clinical epidemiologist at Washington University in St. Louis. He specializes in studying the health effects of medications and chronic diseases. Recently, he commented on a small study that suggested potential vision problems associated with GLP-1 receptor agonists, emphasizing the need for larger, controlled studies to better understand the implications and risks of these widely used diabetes and weight-loss drugs.
Country presence
Recent news mentions
Ziyad Al-Aly is a senior clinical epidemiologist at Washington University in St. Louis and co-author of the study.
Revelan nuevos hallazgos sobre la vacuna anticovidGuatemala· 2026-06-20
Ziyad Al-Aly explains that GLP-1 could act on the brain's reward circuit, reducing cravings associated with substance use.
fármacos para la obesidad y la diabetes podrían ayudar a combatir adicciones, revelan investigacionesGuatemala· 2026-03-07
Ziyad Al-Aly is the study’s lead author and a chief researcher at the VA St. Louis Health Care System.
What to know about how GLP-1 medications might fight addiction
Taiwan· 2026-03-06
Ziyad Al-Aly is a clinical epidemiologist at Washington University in St. Louis who commented on the study's findings.
El Covid y la gripe pueden triplicar el riesgo de infarto
Argentina· 2025-10-30
Ziyad Al-Aly is a senior clinical epidemiologist at the University of Washington in St. Louis, Missouri.
Los efectos a largo plazo que deja el Covid en el cuerpo
Honduras· 2025-03-21
Ziyad Al-Aly is the senior author of the study examining the effects of GLP-1 analogs.
Estudo analisa riscos e benefícios de remédios da classe do Ozempic; efeito no cérebro é destaque
Liechtenstein· 2025-03-18
Dr. Ziyad Al-Aly is the chief of research and development at the VA St. Louis Health Care System and a clinical epidemiologist at Washington University in St. Louis.
What is 'long flu'? Common symptoms people may experience as the US wave worsens
India· 2025-02-15
Ziyad Al-Aly, a clinical epidemiologist at Washington University in St. Louis, was not involved in the study but shared his comments on the findings.
Weight-loss, diabetes drugs linked to vision problems in small study
United States· 2025-02-14
